What the agency is buying
from the notice as publishedThe Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work – spanning structured stakeholder engagement, independent scientific convening, and…
How to get the bid documents
Attachment list not pulled yet; check the source notice.
Open the original listing on SAM.govDetails
- Place of performance
- Silver Spring, Maryland
- Buyer type
- Federal
- Notice type
- Special Notice
- Solicitation no.
- FDASSOC136354
- Size standard
- $19M revenue SBA table, NAICS 541618
- Amendments
- None since Sep 14
- Contact
- Howard Yablon
- Office
- FOOD AND DRUG ADMINISTRATION · FDA NEGOTIATED CONTRACTS BRANCH
Not stated in the notice: estimated value, contract type, period of performance, evaluation criteria, local-presence rule. Check the bid documents.
Contact details from the source notice. Contact the buyer only about this solicitation.
Key dates
- Closed
- Mon, Oct 5
Change log
verified Tue, Oct 6 · 12:30 AM ET- Posted · Special NoticeMon, Sep 14 · 9:20 AM ET
- ClosedMon, Oct 5 · 6:35 AM ET
Change log starts Oct 5, 2026 (tracking began); earlier amendments at SAM.gov are being pulled in.
Report a problem
Notice as published
The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its ts congressionally mandated regulatory mission across 16 project areas
The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work – spanning structured stakeholder engagement, independent scientific convening, and landscape research – is a prerequisite to FDA's ability to develop sound regulatory frameworks and fulfill statutory obligations. Each project area targets a specific gap where FDA cannot act without the scientific foundation, stakeholder input, or evidence infrastructure this contract provides.
The contract is framed as a high-value investment: the cost of inaction – measured in delayed regulatory frameworks, preventable harm, and eroded public trust – exceeds the cost of the engagement. See Attachment for Intent to Sole Source Posting See Attachment for Draft Statement of Work
Similar Food and Drug Administration awards · PSC R799
USAspending.gov, last 36 months1 award matched · tier 2: Food and Drug Administration + PSC R799; nothing from this office. Most recent:
Pro shows every award with the recipient, amount, period and a link to the award record, plus a CSV export. $39/mo.
Sign in or upgradeAwards for this key have not been synced yet.
Similar open RFPs
same PSC R799Listing collected from SAM.gov. Always confirm requirements in the original solicitation before you bid.